Matthew Pauls
Chief Executive Officer bei SAVARA INC.
Vermögen: 6 Mio $ am 31.03.2024
Profil
Matthew Pauls is currently the Chairman & Chief Executive Officer at Savara, Inc. and the Director at Soleno Therapeutics, Inc. He also holds director positions at The Pennington School, The Boys & Girls Clubs of Philadelphia, and Amplo Biotechnology, Inc. Previously, he served as the President, Chief Executive Officer & IR Officer at Cortendo AB, President, Chief Executive Officer & Director at Strongbridge Biopharma Plc, Chairman at Mast Therapeutics, Inc., and Chief Commercial Officer at Insmed, Inc. He also held senior positions at Shire Pharmaceuticals, Inc. Mr. Pauls received his undergraduate degree and MBA from Central Michigan University and his graduate degree from Michigan State University College of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SAVARA, INC.
0,93% | 28.12.2023 | 1 283 674 ( 0,93% ) | 6 Mio $ | 31.03.2024 |
SOLENO THERAPEUTICS INC
-.--% | 15.08.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Matthew Pauls
| Unternehmen | Position | Beginn |
|---|---|---|
| SAVARA INC. | Chief Executive Officer | 11.09.2020 |
| SOLENO THERAPEUTICS, INC. | Director/Board Member | 15.08.2023 |
| The Pennington School | Director/Board Member | - |
| The Boys & Girls Clubs of Philadelphia | Director/Board Member | - |
Amplo Biotechnology, Inc.
 Amplo Biotechnology, Inc. BiotechnologyHealth Technology Amplo Biotechnology, Inc. operates as an American biotechnology company. The CEO of the company is Patricio Sepulveda. | Director/Board Member | - |
Ehemalige bekannte Positionen von Matthew Pauls
| Unternehmen | Position | Ende |
|---|---|---|
| STRONGBRIDGE BIOPHARMA | Chief Executive Officer | 05.11.2019 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Chairman | 01.04.2017 |
| INSMED INCORPORATED | Corporate Officer/Principal | 01.08.2014 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01.04.2013 |
| ░░░░ ░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Matthew Pauls
| Central Michigan University | Masters Business Admin |
| Michigan State University College of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| SAVARA INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Aravas, Inc.
 Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Commercial Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
| The Boys & Girls Clubs of Philadelphia | |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
Amplo Biotechnology, Inc.
Amplo Biotechnology, Inc. BiotechnologyHealth Technology Amplo Biotechnology, Inc. operates as an American biotechnology company. The CEO of the company is Patricio Sepulveda. | Health Technology |
